Sulfonamide

What is a sulfonamide?

Sulfonamides are a group of synthetic compounds characterised by the presence of the sulfonamide functional group (–SO₂NH₂), typically attached to an aromatic ring. The first clinically used sulfonamide, sulfanilamide, was introduced in the 1930s and marked the beginning of modern antimicrobial therapy. These compounds act as competitive inhibitors of dihydropteroate synthase (DHPS), a key enzyme in the bacterial folate synthesis pathway, thereby preventing the production of nucleic acids essential for bacterial growth.

How are sulfonamides used in medicine?

Sulfonamides are employed in treating various bacterial infections, including urinary tract infections, respiratory infections, and certain types of meningitis. Common examples include sulfamethoxazole (often combined with trimethoprim as co-trimoxazole), sulfadiazine, and sulfisoxazole. They are also used in veterinary medicine and, in some cases, as anti-inflammatory agents. However, their use has declined due to increasing resistance and adverse effects such as hypersensitivity reactions, Stevens–Johnson syndrome, and hematological disturbances.

What are the safety and regulatory considerations?

Due to their potential for severe allergic reactions and drug interactions, sulfonamides are subject to strict regulatory oversight under frameworks such as the EU’s REACH, the US FDA’s TSCA, and international standards like ISO and GHS. Quality control in manufacturing is ensured through compliance with pharmacopoeial standards (e.g., BP, EP, USP), and batch testing via HPLC, NMR, and GC-MS. Safety data sheets (SDS) and certificates of analysis (CoA) are required for procurement and regulatory submissions.

Related concepts

Sulfonamide antibiotics are often grouped with other antimicrobials like quinolones and beta-lactams. Resistance mechanisms include mutations in DHPS and increased expression of alternative folate pathways. Cross-reactivity with other sulfonamide-containing drugs must be considered in patient history.